ドライアイ治療薬の世界市場見通し2023年-2029年

◆英語タイトル:Dry Eye Disease Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23LY8499)◆商品コード:MMG23LY8499
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年7月
◆ページ数:76
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Dry Eye Disease Drug Market 調査レポートは次の情報を含め、グローバルにおけるのドライアイ治療薬市場規模と予測を収録しています。・世界のドライアイ治療薬市場:売上、2018年-2023年、2024年-2029年
・世界のドライアイ治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のドライアイ治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「人工涙液」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ドライアイ治療薬のグローバル主要企業は、Allergan、 Alcon、 Novartis、 Santen Pharma、 Johnson & Johnson、 Bausch & Lomb、 Thea pharmaceuticals、 URSAPHARM、 SIMILASAN、 Akorn、 United Laboratories、 Sun Pharmaceutical、 Jianfeng Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ドライアイ治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のドライアイ治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界のドライアイ治療薬市場:タイプ別市場シェア、2022年
・人工涙液、抗炎症薬、その他

世界のドライアイ治療薬市場:用途別、2018年-2023年、2024年-2029年
世界のドライアイ治療薬市場:用途別市場シェア、2022年
・病院、薬局、その他

世界のドライアイ治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界のドライアイ治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるドライアイ治療薬のグローバル売上、2018年-2023年
・主要企業におけるドライアイ治療薬のグローバル売上シェア、2022年
・主要企業におけるドライアイ治療薬のグローバル販売量、2018年-2023年
・主要企業におけるドライアイ治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Allergan、 Alcon、 Novartis、 Santen Pharma、 Johnson & Johnson、 Bausch & Lomb、 Thea pharmaceuticals、 URSAPHARM、 SIMILASAN、 Akorn、 United Laboratories、 Sun Pharmaceutical、 Jianfeng Group

*************************************************************

・調査・分析レポートの概要
ドライアイ治療薬市場の定義
市場セグメント
世界のドライアイ治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のドライアイ治療薬市場規模
世界のドライアイ治療薬市場規模:2022年 VS 2029年
世界のドライアイ治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのドライアイ治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のドライアイ治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:人工涙液、抗炎症薬、その他
ドライアイ治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、薬局、その他
ドライアイ治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別ドライアイ治療薬市場規模 2022年と2029年
地域別ドライアイ治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報(企業概要、事業概要、主要製品、売上、ニュースなど)
Allergan、 Alcon、 Novartis、 Santen Pharma、 Johnson & Johnson、 Bausch & Lomb、 Thea pharmaceuticals、 URSAPHARM、 SIMILASAN、 Akorn、 United Laboratories、 Sun Pharmaceutical、 Jianfeng Group
...

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Disease Drug. This report contains market size and forecasts of Dry Eye Disease Drug in global, including the following market information:
Global Dry Eye Disease Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dry Eye Disease Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dry Eye Disease Drug companies in 2022 (%)
The global Dry Eye Disease Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Artificial Tears Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dry Eye Disease Drug include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM and SIMILASAN, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dry Eye Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dry Eye Disease Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dry Eye Disease Drug Market Segment Percentages, by Type, 2022 (%)
Artificial Tears
Anti-inflammatory Drugs
Other
Global Dry Eye Disease Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dry Eye Disease Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Dry Eye Disease Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dry Eye Disease Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dry Eye Disease Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dry Eye Disease Drug revenues share in global market, 2022 (%)
Key companies Dry Eye Disease Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dry Eye Disease Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dry Eye Disease Drug, market overview.
Chapter 2: Global Dry Eye Disease Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Dry Eye Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dry Eye Disease Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dry Eye Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dry Eye Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dry Eye Disease Drug Overall Market Size
2.1 Global Dry Eye Disease Drug Market Size: 2022 VS 2029
2.2 Global Dry Eye Disease Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dry Eye Disease Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Dry Eye Disease Drug Players in Global Market
3.2 Top Global Dry Eye Disease Drug Companies Ranked by Revenue
3.3 Global Dry Eye Disease Drug Revenue by Companies
3.4 Global Dry Eye Disease Drug Sales by Companies
3.5 Global Dry Eye Disease Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dry Eye Disease Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dry Eye Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dry Eye Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 Dry Eye Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Dry Eye Disease Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dry Eye Disease Drug Market Size Markets, 2022 & 2029
4.1.2 Artificial Tears
4.1.3 Anti-inflammatory Drugs
4.1.4 Other
4.2 By Type – Global Dry Eye Disease Drug Revenue & Forecasts
4.2.1 By Type – Global Dry Eye Disease Drug Revenue, 2018-2023
4.2.2 By Type – Global Dry Eye Disease Drug Revenue, 2024-2029
4.2.3 By Type – Global Dry Eye Disease Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Dry Eye Disease Drug Sales & Forecasts
4.3.1 By Type – Global Dry Eye Disease Drug Sales, 2018-2023
4.3.2 By Type – Global Dry Eye Disease Drug Sales, 2024-2029
4.3.3 By Type – Global Dry Eye Disease Drug Sales Market Share, 2018-2029
4.4 By Type – Global Dry Eye Disease Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dry Eye Disease Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application – Global Dry Eye Disease Drug Revenue & Forecasts
5.2.1 By Application – Global Dry Eye Disease Drug Revenue, 2018-2023
5.2.2 By Application – Global Dry Eye Disease Drug Revenue, 2024-2029
5.2.3 By Application – Global Dry Eye Disease Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Dry Eye Disease Drug Sales & Forecasts
5.3.1 By Application – Global Dry Eye Disease Drug Sales, 2018-2023
5.3.2 By Application – Global Dry Eye Disease Drug Sales, 2024-2029
5.3.3 By Application – Global Dry Eye Disease Drug Sales Market Share, 2018-2029
5.4 By Application – Global Dry Eye Disease Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dry Eye Disease Drug Market Size, 2022 & 2029
6.2 By Region – Global Dry Eye Disease Drug Revenue & Forecasts
6.2.1 By Region – Global Dry Eye Disease Drug Revenue, 2018-2023
6.2.2 By Region – Global Dry Eye Disease Drug Revenue, 2024-2029
6.2.3 By Region – Global Dry Eye Disease Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Dry Eye Disease Drug Sales & Forecasts
6.3.1 By Region – Global Dry Eye Disease Drug Sales, 2018-2023
6.3.2 By Region – Global Dry Eye Disease Drug Sales, 2024-2029
6.3.3 By Region – Global Dry Eye Disease Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dry Eye Disease Drug Revenue, 2018-2029
6.4.2 By Country – North America Dry Eye Disease Drug Sales, 2018-2029
6.4.3 US Dry Eye Disease Drug Market Size, 2018-2029
6.4.4 Canada Dry Eye Disease Drug Market Size, 2018-2029
6.4.5 Mexico Dry Eye Disease Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dry Eye Disease Drug Revenue, 2018-2029
6.5.2 By Country – Europe Dry Eye Disease Drug Sales, 2018-2029
6.5.3 Germany Dry Eye Disease Drug Market Size, 2018-2029
6.5.4 France Dry Eye Disease Drug Market Size, 2018-2029
6.5.5 U.K. Dry Eye Disease Drug Market Size, 2018-2029
6.5.6 Italy Dry Eye Disease Drug Market Size, 2018-2029
6.5.7 Russia Dry Eye Disease Drug Market Size, 2018-2029
6.5.8 Nordic Countries Dry Eye Disease Drug Market Size, 2018-2029
6.5.9 Benelux Dry Eye Disease Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dry Eye Disease Drug Revenue, 2018-2029
6.6.2 By Region – Asia Dry Eye Disease Drug Sales, 2018-2029
6.6.3 China Dry Eye Disease Drug Market Size, 2018-2029
6.6.4 Japan Dry Eye Disease Drug Market Size, 2018-2029
6.6.5 South Korea Dry Eye Disease Drug Market Size, 2018-2029
6.6.6 Southeast Asia Dry Eye Disease Drug Market Size, 2018-2029
6.6.7 India Dry Eye Disease Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dry Eye Disease Drug Revenue, 2018-2029
6.7.2 By Country – South America Dry Eye Disease Drug Sales, 2018-2029
6.7.3 Brazil Dry Eye Disease Drug Market Size, 2018-2029
6.7.4 Argentina Dry Eye Disease Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dry Eye Disease Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dry Eye Disease Drug Sales, 2018-2029
6.8.3 Turkey Dry Eye Disease Drug Market Size, 2018-2029
6.8.4 Israel Dry Eye Disease Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Dry Eye Disease Drug Market Size, 2018-2029
6.8.6 UAE Dry Eye Disease Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Allergan
7.1.1 Allergan Company Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Dry Eye Disease Drug Major Product Offerings
7.1.4 Allergan Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.1.5 Allergan Key News & Latest Developments
7.2 Alcon
7.2.1 Alcon Company Summary
7.2.2 Alcon Business Overview
7.2.3 Alcon Dry Eye Disease Drug Major Product Offerings
7.2.4 Alcon Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.2.5 Alcon Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Dry Eye Disease Drug Major Product Offerings
7.3.4 Novartis Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Santen Pharma
7.4.1 Santen Pharma Company Summary
7.4.2 Santen Pharma Business Overview
7.4.3 Santen Pharma Dry Eye Disease Drug Major Product Offerings
7.4.4 Santen Pharma Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.4.5 Santen Pharma Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Dry Eye Disease Drug Major Product Offerings
7.5.4 Johnson & Johnson Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Bausch & Lomb
7.6.1 Bausch & Lomb Company Summary
7.6.2 Bausch & Lomb Business Overview
7.6.3 Bausch & Lomb Dry Eye Disease Drug Major Product Offerings
7.6.4 Bausch & Lomb Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.6.5 Bausch & Lomb Key News & Latest Developments
7.7 Thea pharmaceuticals
7.7.1 Thea pharmaceuticals Company Summary
7.7.2 Thea pharmaceuticals Business Overview
7.7.3 Thea pharmaceuticals Dry Eye Disease Drug Major Product Offerings
7.7.4 Thea pharmaceuticals Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.7.5 Thea pharmaceuticals Key News & Latest Developments
7.8 URSAPHARM
7.8.1 URSAPHARM Company Summary
7.8.2 URSAPHARM Business Overview
7.8.3 URSAPHARM Dry Eye Disease Drug Major Product Offerings
7.8.4 URSAPHARM Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.8.5 URSAPHARM Key News & Latest Developments
7.9 SIMILASAN
7.9.1 SIMILASAN Company Summary
7.9.2 SIMILASAN Business Overview
7.9.3 SIMILASAN Dry Eye Disease Drug Major Product Offerings
7.9.4 SIMILASAN Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.9.5 SIMILASAN Key News & Latest Developments
7.10 Akorn
7.10.1 Akorn Company Summary
7.10.2 Akorn Business Overview
7.10.3 Akorn Dry Eye Disease Drug Major Product Offerings
7.10.4 Akorn Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.10.5 Akorn Key News & Latest Developments
7.11 United Laboratories
7.11.1 United Laboratories Company Summary
7.11.2 United Laboratories Dry Eye Disease Drug Business Overview
7.11.3 United Laboratories Dry Eye Disease Drug Major Product Offerings
7.11.4 United Laboratories Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.11.5 United Laboratories Key News & Latest Developments
7.12 Sun Pharmaceutical
7.12.1 Sun Pharmaceutical Company Summary
7.12.2 Sun Pharmaceutical Dry Eye Disease Drug Business Overview
7.12.3 Sun Pharmaceutical Dry Eye Disease Drug Major Product Offerings
7.12.4 Sun Pharmaceutical Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.12.5 Sun Pharmaceutical Key News & Latest Developments
7.13 Jianfeng Group
7.13.1 Jianfeng Group Company Summary
7.13.2 Jianfeng Group Dry Eye Disease Drug Business Overview
7.13.3 Jianfeng Group Dry Eye Disease Drug Major Product Offerings
7.13.4 Jianfeng Group Dry Eye Disease Drug Sales and Revenue in Global (2018-2023)
7.13.5 Jianfeng Group Key News & Latest Developments
8 Global Dry Eye Disease Drug Production Capacity, Analysis
8.1 Global Dry Eye Disease Drug Production Capacity, 2018-2029
8.2 Dry Eye Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Dry Eye Disease Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dry Eye Disease Drug Supply Chain Analysis
10.1 Dry Eye Disease Drug Industry Value Chain
10.2 Dry Eye Disease Drug Upstream Market
10.3 Dry Eye Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dry Eye Disease Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dry Eye Disease Drug in Global Market
Table 2. Top Dry Eye Disease Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dry Eye Disease Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dry Eye Disease Drug Revenue Share by Companies, 2018-2023
Table 5. Global Dry Eye Disease Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Dry Eye Disease Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dry Eye Disease Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Dry Eye Disease Drug Product Type
Table 9. List of Global Tier 1 Dry Eye Disease Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dry Eye Disease Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dry Eye Disease Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dry Eye Disease Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dry Eye Disease Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dry Eye Disease Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Dry Eye Disease Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Dry Eye Disease Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dry Eye Disease Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dry Eye Disease Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dry Eye Disease Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Dry Eye Disease Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Dry Eye Disease Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dry Eye Disease Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dry Eye Disease Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dry Eye Disease Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Dry Eye Disease Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dry Eye Disease Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dry Eye Disease Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Dry Eye Disease Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dry Eye Disease Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dry Eye Disease Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dry Eye Disease Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dry Eye Disease Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dry Eye Disease Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dry Eye Disease Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dry Eye Disease Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dry Eye Disease Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Dry Eye Disease Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dry Eye Disease Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dry Eye Disease Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dry Eye Disease Drug Sales, (K Units), 2024-2029
Table 46. Allergan Company Summary
Table 47. Allergan Dry Eye Disease Drug Product Offerings
Table 48. Allergan Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. Alcon Company Summary
Table 51. Alcon Dry Eye Disease Drug Product Offerings
Table 52. Alcon Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Alcon Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Dry Eye Disease Drug Product Offerings
Table 56. Novartis Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Santen Pharma Company Summary
Table 59. Santen Pharma Dry Eye Disease Drug Product Offerings
Table 60. Santen Pharma Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Santen Pharma Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Dry Eye Disease Drug Product Offerings
Table 64. Johnson & Johnson Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Bausch & Lomb Company Summary
Table 67. Bausch & Lomb Dry Eye Disease Drug Product Offerings
Table 68. Bausch & Lomb Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Bausch & Lomb Key News & Latest Developments
Table 70. Thea pharmaceuticals Company Summary
Table 71. Thea pharmaceuticals Dry Eye Disease Drug Product Offerings
Table 72. Thea pharmaceuticals Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Thea pharmaceuticals Key News & Latest Developments
Table 74. URSAPHARM Company Summary
Table 75. URSAPHARM Dry Eye Disease Drug Product Offerings
Table 76. URSAPHARM Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. URSAPHARM Key News & Latest Developments
Table 78. SIMILASAN Company Summary
Table 79. SIMILASAN Dry Eye Disease Drug Product Offerings
Table 80. SIMILASAN Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. SIMILASAN Key News & Latest Developments
Table 82. Akorn Company Summary
Table 83. Akorn Dry Eye Disease Drug Product Offerings
Table 84. Akorn Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Akorn Key News & Latest Developments
Table 86. United Laboratories Company Summary
Table 87. United Laboratories Dry Eye Disease Drug Product Offerings
Table 88. United Laboratories Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. United Laboratories Key News & Latest Developments
Table 90. Sun Pharmaceutical Company Summary
Table 91. Sun Pharmaceutical Dry Eye Disease Drug Product Offerings
Table 92. Sun Pharmaceutical Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Sun Pharmaceutical Key News & Latest Developments
Table 94. Jianfeng Group Company Summary
Table 95. Jianfeng Group Dry Eye Disease Drug Product Offerings
Table 96. Jianfeng Group Dry Eye Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Jianfeng Group Key News & Latest Developments
Table 98. Dry Eye Disease Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Dry Eye Disease Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Dry Eye Disease Drug Production by Region, 2018-2023 (K Units)
Table 101. Global Dry Eye Disease Drug Production by Region, 2024-2029 (K Units)
Table 102. Dry Eye Disease Drug Market Opportunities & Trends in Global Market
Table 103. Dry Eye Disease Drug Market Drivers in Global Market
Table 104. Dry Eye Disease Drug Market Restraints in Global Market
Table 105. Dry Eye Disease Drug Raw Materials
Table 106. Dry Eye Disease Drug Raw Materials Suppliers in Global Market
Table 107. Typical Dry Eye Disease Drug Downstream
Table 108. Dry Eye Disease Drug Downstream Clients in Global Market
Table 109. Dry Eye Disease Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dry Eye Disease Drug Segment by Type in 2022
Figure 2. Dry Eye Disease Drug Segment by Application in 2022
Figure 3. Global Dry Eye Disease Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dry Eye Disease Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dry Eye Disease Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Dry Eye Disease Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dry Eye Disease Drug Revenue in 2022
Figure 9. By Type - Global Dry Eye Disease Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Dry Eye Disease Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Dry Eye Disease Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Dry Eye Disease Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Dry Eye Disease Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dry Eye Disease Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 23. US Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 28. Germany Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 37. China Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 44. Brazil Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dry Eye Disease Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dry Eye Disease Drug Sales Market Share, 2018-2029
Figure 48. Turkey Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dry Eye Disease Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dry Eye Disease Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dry Eye Disease Drug by Region, 2022 VS 2029
Figure 54. Dry Eye Disease Drug Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ドライアイ治療薬の世界市場見通し2023年-2029年(Dry Eye Disease Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆